Memorial Healthcare
Owosso, Michigan, United States
Emergency room in Owosso, Michigan
826 W King St, Owosso, MI 48867
About Memorial Healthcare
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
3
EMD Serono Research & Development Institute, Inc.
2
NSABP Foundation Inc
2
Biogen
1
Vertos Medical, Inc.
1
Washington University School of Medicine
1
Clinical Trials at Memorial Healthcare
During the past decade, Memorial Healthcare conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
2009-05-01
2018-02-01
Completed
1,613
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
2017-03-10
2024-12-01
Recruiting
4,000
A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
2019-07-22
2026-11-15
Active, not recruiting
295
A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
2019-05-21
2026-02-21
Active, not recruiting
100
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168)
2020-06-30
2023-09-06
Active, not recruiting
900
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168)
2020-09-24
2024-08-01
Active, not recruiting
1,131
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Memorial Healthcare" #1 sponsor was "Sanofi" with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials
sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Vertos Medical, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Healthcare"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Memorial Healthcare
According to Clinical.Site data, the most researched conditions in "Memorial Healthcare" are
"Breast Cancer" (2 trials), "Multiple Sclerosis" (2 trials), "Lumbar Spinal Stenosis" (1 trials), "Primary Progressive Multiple Sclerosis" (1 trials) and "Relapsing Forms of MS" (1 trials). Many other conditions were trialed in "Memorial Healthcare" in a lesser frequency.
Clinical Trials Intervention Types at Memorial Healthcare
Most popular intervention types in "Memorial Healthcare" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tolebrutinib" (3 trials), "Cladribine Tablets" (2 trials), "Placebo to match Tolebrutinib" (2 trials), "Diroximel Fumarate" (1 trials) and "MILD" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Memorial Healthcare
The vast majority of trials in "Memorial Healthcare" are
8 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Memorial Healthcare
Currently, there are NaN active trials in "Memorial Healthcare".
undefined are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Memorial Healthcare,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Memorial Healthcare, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Memorial Healthcare
Memorial Healthcare has several departments that took part in Clinical trials: "McLaren Cancer Institute-Owosso" - 14 trials, "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" - 4 trials
Departments List
Name
City
Trials